Development of a targeted differential mobility spectrometry UHPLC-MS/MS quantitation method for free long-chain and hydroxylated fatty acids
Analytical and Bioanalytical Chemistry · 13.11.2026
DOI: 10.1007/s00216-026-06869-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical and Bioanalytical Chemistry, online erschienen am 13.11.2026. Verfasst von Miriam Wimmer und 5 weiteren Autor:innen. Beteiligte Einrichtung: TUM Graduate School, School of Life Sciences, Technical University of Munich, Alte Akademie 8, 85354, Freising, Germany. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Themen: Mobilisation
Abstract (Originalsprache)
Despite the well-established roles of long-chain fatty acids in animal and human metabolism, the involvement of their hydroxylated metabolites in carcinogenesis remains unclear, primarily due to the lack of robust quantitative analytical methods. In this study, we present a novel analytical approach that enables the quantification of cis- and trans-isomers of long-chain fatty acids and their hydroxylated metabolites in tumor and non-tumor colorectal tissues of mice. Using a combination of liquid chromatography, differential mobility spectrometry, and tandem mass spectrometry (LC-DMS-MS/MS), we achieved the separation and quantification of a diverse range of free fatty acids, including nine saturated, eleven monounsaturated, six polyunsaturated, four carboxylated, and nine hydroxylated fatty acids, covering various degrees of saturation and isomerism. The method was validated with deuterated and 13C-labelled isotopologs of non-hydroxylated fatty acids. Our comparative analysis of tumor and non-tumor colorectal tissues from mice revealed distinctive alterations in the profiles of individual analytes, particularly regarding the long-chain polyunsaturated fatty acid C20:4 and its hydroxylated metabolites C20:4-5-OH and C20:4-12-OH. These characteristic differences in concentration will enable novel insights into the potential involvement of specific long-chain hydroxylated fatty acids in the pathogenesis of colorectal tumors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- TUM Graduate School, School of Life Sciences, Technical University of Munich, Alte Akademie 8, 85354, Freising, Germany.
- Leibniz-Institute for Food Systems Biology at the Technical University of Munich, Lise-Meitner-Straße 34, 85354, Freising, Germany.
- ZIEL-Institute for Food and Health, Technical University of Munich, Weihenstephaner Berg 1, 85354, Freising, Germany.
- Institute for Stroke and Dementia Research, Ludwig Maximilians-University of Munich, Feodor-Lynen-Straße 17, 81377, Munich, Germany.
- Chair of Nutrition and Immunology, School of Life Sciences, Technical University of Munich, Gregor-Mendel-Str. 2, 85354, Freising, Germany.
- Institute of Physiological Chemistry, Faculty of Chemistry, University of Vienna, Josef-Holaubek-Platz 2, 1090, Vienna, Austria.
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Wimmer, M., Sorbie, A., Coleman, O. I., Haller, D., Somoza, V., & Dunkel, A. (2026). Development of a targeted differential mobility spectrometry UHPLC-MS/MS quantitation method for free long-chain and hydroxylated fatty acids. Analytical and Bioanalytical Chemistry. https://doi.org/10.1007/s00216-026-06869-5
Vancouver
Wimmer M, Sorbie A, Coleman OI, Haller D, Somoza V, Dunkel A. Development of a targeted differential mobility spectrometry UHPLC-MS/MS quantitation method for free long-chain and hydroxylated fatty acids. Analytical and Bioanalytical Chemistry. 2026. doi:10.1007/s00216-026-06869-5
BibTeX
@article{Wimmer2026,
author = {Wimmer, Miriam and Sorbie, Adam and Coleman, Olivia I and Haller, Dirk and Somoza, Veronika and Dunkel, Andreas},
title = {Development of a targeted differential mobility spectrometry UHPLC-MS/MS quantitation method for free long-chain and hydroxylated fatty acids},
journal = {Analytical and Bioanalytical Chemistry},
year = {2026},
doi = {10.1007/s00216-026-06869-5}
}
EUVIMED